1. A Covid drug derived from the immune cells of virus survivors gives better protection than vaccines after six months and could last for a year, trial results suggest. Yesterday, AstraZeneca announced that its AZD7442 antibody injection reduces the risk of symptomatic Covid by 83 per cent six months after a single dose. In contrast, vaccine protection
Keep reading with a 7-day free trial
Subscribe to News Items to keep reading this post and get 7 days of free access to the full post archives.